The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: A systematic review and meta-analysis

Journal of Clinical and Experimental Neuropsychology

Volumn 36, Issue 7, 2014, Pages 691-700

  Stranks, Elizabeth K ^a   Crowe, Simon F ^a  

^a LA TROBE UNIVERSITY   (Australia)

Author keywords

Cognitive effects; Eszopiclone; Meta analysis; Zaleplon; Zolpidem; Zopiclone

Indexed keywords

ACETAMIDE DERIVATIVE; AZABICYCLO DERIVATIVE; ESZOPICLONE; HYPNOTIC SEDATIVE AGENT; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; ZALEPLON; ZOLPIDEM; ZOPICLONE;

ATTENTION; DRUG EFFECTS; HUMAN; MEMORY; META ANALYSIS; PSYCHOMOTOR PERFORMANCE;

ACETAMIDES; ATTENTION; AZABICYCLO COMPOUNDS; HUMANS; HYPNOTICS AND SEDATIVES; MEMORY; PIPERAZINES; PSYCHOMOTOR PERFORMANCE; PYRIDINES; PYRIMIDINES;

EID: 84911991528     PISSN: 13803395     EISSN: 1744411X     Source Type: Journal    
DOI: 10.1080/13803395.2014.928268     Document Type: Article

References (52)

1. Allain, H., Bentue-Ferrer, D., Tarral, A., & Gandon, J.-M. (2003). Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo. European Journal of Clinical Pharmacology, 59 (3), 179-188.
2. Anderson-Hanley, C., Sherman, M. L., Riggs, R., Agocha, V. B., & Compas, B. E. (2003). Neuropsychological effects of treatments for adults with cancer: A meta-analysis and review of the literature. Journal of the International Neuropsychological Society, 9 (7), 967-982.
3. Barker, M. J., Greenwood, K. M., Jackson, M., & Crowe, S. F. (2004). Cognitive effects of long-term benzodiazepine use: A meta-analysis. CNS Drugs, 18 (1), 37-48.
4. Barker, M. J., Jackson, M., Greenwood, K. M., & Crowe, S. F. (2003). Cognitive effects of benzodiazepine use: A review. Australian Psychologist, 38 (3), 202-213.
5. Bensimon, G., Foret, J., Warot, D., Lacomblez, L., Thiercelin, J. F., & Simon, P. (1990). Daytime wakefulness following a bedtime oral dose of zolpidem 20 mg, flunitrazepam 2 mg and placebo. British Journal of Clinical Pharmacology, 30 (3), 463-469.
6. Blin, O., Micallef, J., Audebert, C., & Legangneux, E. (2006). A double-blind, placebo- and flurazepam-controlled investigation of the residual psychomotor and cognitive effects of modified release zolpidem in young healthy volunteers. Journal of Clinical Psychopharmacology, 26 (3), 284-289.
7. Boyle, J., Trick, L., Johnsen, S., Roach, J., & Rubens, R. (2008). Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone. Human Psychopharmacology, 23 (5), 385-397. doi: 10.1002/hup.936
8. Chilcott, L. A., & Shapiro, C. M. (1996). The socioeconomic impact of insomnia. Pharmacoeconomics, 10 (1), 1-14.
9. Cooper, H. (2010). Research synthesis and meta-analysis. Thousand Oaks, CA: Sage.
10. Cotroneo, A., Gareri, P., Nicoletti, N., Lacava, R., Grassone, D., Maina, E., Cabodi, S. (2007). Effectiveness and safety of hypnotic drugs in the treatment of insomnia in over 70-year old people. Archives of Gerontology and Geriatrics, 44 (Suppl. 1), 121-124. doi: 10.1016/j.archger.2007.01.018
11. Danjou, P., Paty, I., Fruncillo, R., Worthington, P., Unruh, M., Cevallos, W., & Martin, P. (1999). A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening. British Journal of Clinical Pharmacology, 48 (3), 367-374.
12. Diekelmann, S., & Born, J. (2010). The memory function of sleep. Nature Reviews Neuroscience, 11 (2), 114-126.
13. Dingemanse, J., Bury, M., Bock, J., & Joubert, P. (1995). Comparative pharmacodynamics of Ro 41-3696, a new hypnotic, and zolpidem after night-time administration to healthy subjects. Psychopharmacology, 122 (2), 169-174.
14. Doghramji, P. P. (2001). Treatment of insomnia with zaleplon, a novel sleep medication. International Journal of Clinical Practice, 55 (5), 329-334.
15. Dündar, Y., Dodd, S., Strobl, J., Boland, A., Dickson, R., & Walley, T. (2004). Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: A systematic review and meta-analysis. Human Psychopharmacology: Clinical and Experimental, 19 (5), 305-322.
16. Ebert, B., Wafford, K. A., & Deacon, S. (2006). Treating insomnia: Current and investigational pharmacological approaches. Pharmacology & Therapeutics, 112 (3), 612-629.
17. Fairweather, D. B., Kerr, J. S., & Hindmarch, I. (1992). The effects of acute and repeated doses of zolpidem on subjective sleep, psychomotor performance and cognitive function in elderly volunteers. European Journal of Clinical Pharmacology, 43 (6), 597-601.
18. Gieschke, R., Cluydts, R., Dingemanse, J., De Roeck, J., & De Cock, W. (1994). Effects of bretazenil vs. zolpidem and placebo on experimentally induced sleep disturbance in healthy volunteers. Methods & Findings in Experimental & Clinical Pharmacology, 16 (9), 667-675.
19. Harrison, C., Subhan, Z., & Hindmarch, I. (1984). Residual effects of zopiclone and benzodiazepine hypnotics on psychomotor performance related to car driving. Drugs under Experimental and Clinical Research, 11 (12), 823-829.
20. Harvey, S. T., & Taylor, J. E. (2010). A meta-analysis of the effects of psychotherapy with sexually abused children and adolescents. Clinical Psychology Review, 30 (5), 517-535.
21. Hemmeter, U., Muller, M., Bischof, R., Annen, B., & Holsboer-Trachsler, E. (2000). Effect of zopiclone and temazepam on sleep EEG parameters, psychomotor and memory functions in healthy elderly volunteers. Psychopharmacology, 147 (4), 384-396. doi: 10.1007/s002130050007
22. Hindmarch, I., Legangneux, E., Stanley, N., Emegbo, S., & Dawson, J. (2006). A double-blind, placebo-controlled investigation of the residual psychomotor and cognitive effects of zolpidem-MR in healthy elderly volunteers. British Journal of Clinical Pharmacology, 62 (5), 538-545.
23. Hoffmann, F. (2013). Perceptions of German GPs on benefits and risks of benzodiazepines and Z-drugs. Swiss Medical Weekly, 143, w13745.
24. Hollingworth, S. A., & Siskind, D. J. (2010). Anxiolytic, hypnotic and sedative medication use in Australia. Pharmacoepidemiology and Drug Safety, 19 (3), 280-288.
25. Huedo-Medina, T. B., Kirsch, I., Middlemass, J., Klonizakis, M., & Siriwardena, A. N. (2011). Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: Meta-analysis of data submitted to the Food and Drug Administration. BMJ: British Medical Journal, 345, e8343. doi: 10.1136/bmj.e8343
26. Hutchinson, A. D., & Mathias, J. L. (2007). Neuropsychological deficits in frontotemporal dementia and Alzheimers disease: A meta-analytic review. Journal of Neurology, Neurosurgery & Psychiatry, 78 (9), 917-928.
27. Leufkens, T. R., Lund, J. S., & Vermeeren, A. (2009). Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem. Journal of Sleep Research, 18 (4), 387-396. doi: 10.1111/j.1365-2869.2009.00746.x
28. Leufkens, T. R., & Vermeeren, A. (2009). Highway driving in the elderly the morning after bedtime use of hypnotics: A comparison between temazepam 20 mg, zopiclone 7.5 mg, and placebo. Journal of Clinical Psychopharmacology, 29 (5), 432-438. doi: 10.1097/JCP.0b013e3181b57b43
29. Lezak, M. D., Howieson, D. B., Bigler, E. D., & Tranel, D. (2012). Neuropsychological assessment (5th ed.). New York, NY: Oxford University Press.
30. Lipsey, M. W., & Wilson, D. B. (2001). Practical meta-analysis. Thousand Oaks, CA: Sage.
31. Mattila, M., Aranko, K., & Paakkari, I. (1994). Effects of psychotropic drugs on digit substitution: Comparison of the computerized symbol-digit substitution and traditional digit-symbol substitution tests. Journal of Psychopharmacology, 8 (2), 81-87. doi: 10.1177/026988119400800202
32. Mattila, M., & Mattila-Evenden, M. (1997). Effects of alcohol and hypnosedative drugs on digit-symbol substitution: Comparison of two different computerized tests. Journal of Psychopharmacology, 11 (4), 313-317. doi: 10.1177/026988119701100405
33. Mednick, S. C., McDevitt, E. A., Walsh, J. K., Wamsley, E., Paulus, M., Kanady, J. C., & Drummond, S. P. (2013). The critical role of sleep spindles in hippocampal-dependent memory: A pharmacology study. The Journal of Neuroscience, 33 (10), 4494-4504.
34. Melendez, J., Galli, I., Boric, K., Ortega, A., Zuniga, L., Henriquez-Roldan, C. F., & Cardenas, A. M. (2005). Zolpidem and triazolam do not affect the nocturnal sleep-induced memory improvement. Psychopharmacology, 181 (1), 21-26.
35. Mets, M. A., de Vries, J. M., de Senerpont Domis, L. M., Volkerts, E. R., Olivier, B., & Verster, J. C. (2011). Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects. Sleep: Journal of Sleep and Sleep Disorders Research, 34 (10), 1327-1334.
36. Morgan, P. T., Kehne, J. H., Sprenger, K. J., & Malison, R. T. (2010). Retrograde effects of triazolam and zolpidem on sleep-dependent motor learning in humans. Journal of Sleep Research, 19. (1, Pt. 2), 157-164. doi: 10.1111/j.1365-2869.2009.00757.x
37. National Institute for Clinical Excellence. (2004). Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia (Technology Appraisal Guide 77). London: NICE.
38. Quera-Salva, M. A., McCann, C., Boudet, J., Frisk, M., Borderies, P., & Meyer, P. (1994). Effects of zolpidem on sleep architecture, night time ventilation, daytime vigilance and performance in heavy snorers. British Journal of Clinical Pharmacology, 37 (6), 539-543.
39. Roehrs, T., Merlotti, L., Zorick, F., & Roth, T. (1994). Sedative, memory, and performance effects of hypnotics. Psychopharmacology, 116 (2), 130-134.
40. Rosenthal, R. (1995). Writing meta-analytic reviews. Psychological Bulletin, 118 (2), 183.
41. Sicard, B. A., Trocherie, S., Moreau, J., Vieillefond, H., & Court, L. A. (1993). Evaluation of zolpidem on alertness and psychomotor abilities among aviation ground personnel and pilots. Aviation Space & Environmental Medicine, 64 (5), 371-375.
42. Silva, A., Collao, A., Orellana, M., Meléndez, J., Caviedes, P., & Cárdenas, A. M. (2003). Zopiclone, but not brotizolam, impairs memory storage during sleep. Neuroscience Research, 47 (2), 241-243.
43. Siriwardena, A. N., Qureshi, Z., Gibson, S., Collier, S., & Latham, M. (2006). GPs attitudes to benzodiazepine and "Z-drug" prescribing: A barrier to implementation of evidence and guidance on hypnotics. British Journal of General Practice, 56 (533), 964-967.
44. Stewart, A., Bielajew, C., Collins, B., Parkinson, M., & Tomiak, E. (2006). A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. The Clinical Neuropsychologist, 20 (1), 76-89.
45. Stone, B. M., Turner, C., Mills, S. L., Paty, I., Patat, A., Darwish, M., & Danjou, P. (2002). Noise-induced sleep maintenance insomnia: Hypnotic and residual effects of zaleplon. British Journal of Clinical Pharmacology, 53 (2), 196-202.
46. Strauss, E., Sherman, E. M. S., & Spreen, O. (2006). A compendium of neuropsychological tests: Administration, norms, and commentary (3rd ed.). New York, NY: Oxford University Press.
47. Tafti, M., Besset, A., & Billiard, M. (1992). Effects of zopiclone on subjective evaluation of sleep and daytime alertness and on psychomotor and physical performance tests in athletes. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 16 (1), 55-63.
48. Terzano, M., Rossi, M., Palomba, V., Smerieri, A., & Parrino, L. (2003). New drugs for insomnia: Comparative tolerability of zopiclone, zolpidem and zaleplon. Drug Safety, 26 (4), 261-282.
49. Thomas, M., Sing, H., Belenky, G., Holcomb, H., Mayberg, H., Dannals, R., Rowland, L. (2008). Neural basis of alertness and cognitive performance impairments during sleepiness: I. Effects of 24 h of sleep deprivation on waking human regional brain activity. Journal of Sleep Research, 9 (4), 335-352.
50. Uchiumi, M., Isawa, S., Suzuki, M., & Murasaki, M. (2000). The effects of zolpidem and zopiclone on daytime sleepiness and psychomotor performance. Nihon Shinkei Seishin Yakurigaku Zasshi, 20 (3), 123-130.
51. Vermeeren, A., Riedel, W. J., van Boxtel, M. P. J., Darwish, M., Paty, I., & Patat, A. (2002). Differential residual effects of zaleplon and zopiclone on actual driving: A comparison with a low dose of alcohol. Sleep, 25 (2), 224-231.
52. Warot, D., Bensimon, G., Danjou, P., & Puech, A. J. (1987). Comparative effects of zopiclone, triazolam and placebo on memory and psychomotor performance in healthy volunteers. Fundamental & Clinical Pharmacology, 1 (2), 145-152.